ALK and neoplasm: CXCR3 was expressed in the tumor cells in 8/13 ALK− ALCL cases (61%), 6/11 ALK+ ALCL cases (55%) and 5/11 cHL cases (45%) (Figure 1A, Supplementary Table S1).